SarahDoernbergMD
Infectious Disease • San Francisco, CAAssistant Professor, Medicine, University of California, San Francisco, School of
Dr. Doernberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1528
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011- University of California (San Francisco)Residency, Internal Medicine, 2006 - 2009
Yale School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Olorofim Aspergillus Infection Study Start of enrollment: 2022 Mar 31
Roles: Contact
- Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial Start of enrollment: 2024 Feb 22
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- The Positioning of Ceftobiprole in the Treatment of Staphylococcus aureus Bacteremia.Daniel J Minter, Ayesha Appa, Henry F Chambers, Sarah B Doernberg
Clinical Infectious Diseases. 2024-12-17 - 1 citationsImpact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial.Ritu Banerjee, Abhigya Giri, Lauren Komarow, Maria Souli, Sarah B Doernberg
Microbiology Spectrum. 2024-12-16 - Development of antibiotic metrics for hospitalists via multi-institutional modified Delphi survey.Allison Bond, Sandra Oreper, Priya Prasad, Emily Abdoler, Sarah Doernberg
Journal of Hospital Medicine. 2024-08-01
Journal Articles
- Association of Race/Ethnicity with Likeliness of COVID-19 Vaccine Uptake Among Health Workers and the General Population in the San Francisco Bay AreaKevin Grumbach, Sarah B Doernberg, JAMA Internal Medicine
Press Mentions
As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing StrongerJuly 15th, 2022- As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing StrongerJuly 15th, 2022
- ‘Zero COVID Deaths’: Why Officials Are Pushing Paxlovid to Defang the CoronavirusMay 13th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
